Potential use of a liposome-encapsulated mixture of lipopolysaccharide core types (R1, R2, R3 and R4) of Escherichia coli in controlling colisepticaemia in chickens

Journal of Medical Microbiology

Volumn 59, Issue 1, 2010, Pages 100-107

  Dissanayake, D R Anuruddhika ^a   Wijewardana, Thula G ^a   Gunawardena, Gnana A ^b   Poxton, Ian R ^c  

^a UNIVERSITY OF PERADENIYA   (Sri Lanka)

^b Veterinary Research Institute   (Sri Lanka)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CHOLESTEROL; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; LIPOSOME; NITRIC OXIDE; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLSERINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; BACTERIAL STRAIN; BODY WEIGHT; BRAIN; CHICKEN; COLISEPTICAEMIA; CONTROLLED STUDY; ENCAPSULATION; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; FEMALE; GENETIC TRANSCRIPTION; IMMUNIZATION; LIMULUS LYSATE TEST; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BACTERIAL VACCINES; CELL LINE; CHICKENS; CYTOKINES; ESCHERICHIA COLI INFECTIONS; GENE EXPRESSION REGULATION; LIPOPOLYSACCHARIDES; LIPOSOMES; MACROPHAGES; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; POULTRY DISEASES; RNA, MESSENGER;

EID: 73649116673     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.014720-0     Document Type: Article

References (32)

1. Arp, L. H. (1980). Consequences of active or passive immunization of turkeys against Escherichia coli O78. Avian Dis 24, 808-815.
2. Bennett-Guerrero, E., McIntosh, T. J., Barclay, G. R., Snyder, D. S., Gibbs, R. J., Mythen, M. G. & Poxton, I. R. (2000). Preparation and preclinical evaluation of a novel liposomal complete-core lipopolysaccharides vaccine. Infect Immun 68, 6202-6208.
3. Chhibber, S., Wadhwa, S. & Yadav, V. (2004). Protective role of liposome incorporated lipopolysaccharide antigen of Klebsiella pneumoniae in a rat model of lobar pneumonia. Jpn J Infect Dis 57, 150-155.
4. Deb, J. R. & Harry, E. G. (1976). Laboratory trials with inactivated vaccines against Escherichia coli 078 : K80 infection in fowls. Res Vet Sci 20, 131-138.
5. Dijkstra, J., Mellors, J. W., Ryan, J. L. & Szoka, F. C. (1987). Modulation of the biological activity of bacterial endotoxin by incorporation into liposomes. J Immun 138, 2663-2670.
6. Dijkstra, J., Larrick, J. W., Ryan, J. L. & Szoka, F. C. (1988). Incorporation of LPS in liposomes diminishes its ability to induce tumoricidal activity and tumor necrosis factor secretion in murine macrophages. J Leukoc Biol 43, 436-444.
7. Dijkstra, J., Mellors, J. W. & Ryan, J. L. (1989). Altered in vivo activity of liposome-incorporated lipopolysaccharide and lipid A. Infect Immun 57, 3357-3363.
8. Dissanayake, D. R. A., Wijewardana, T. G., Gunawardena, G. A. & Poxton, I. R. (2008). Distribution of lipopolysaccharide core types among avian pathogenic Escherichia coli in relation to the major phylogenetic groups. Vet Microbiol 132, 355-363.
9. Elkins, K. L., Stashak, P. W. & Baker, P. J. (1987). Mechanisms of specific immunological unresponsiveness to bacterial lipopolysaccharide. Infect Immun 55, 3093-3102.
10. Erridge, C., Stewart, J., Bennett-Guerrero, E., McIntosh, T. J. & Poxton, I. R. (2002). The biological activity of a liposomal complete core lipopolysaccharide vaccine. J Endotoxin Res 8, 39-46.
11. Frommer, A., Freidlin, P. J., Bock, R. R., Leitner, G., Chaffer, M. & Heller, E. D. (1994). Experimental vaccination of young chickens with a live, non-pathogenic strain of Escherichia coli. Avian Pathol 23, 425-433.
12. Galanos, C. & Lüderitz, O. (1984). Lipopolysaccharide: properties of an amphipathic molecule. In HandBook of Endotoxin. 1. Chemistry of Endotoxin, pp. 46-58. Edited by E. Th. Rietschel. Amsterdam: Elsevier.
13. Gibb, A. P., Barclay, G. R., Poxton, I. R. & di Padova, F. (1992). Frequencies of lipopolysaccharide core types among clinical isolates of Escherichia coli defined with monoclonal antibodies. J Infect Dis 166, 1051-1057.
14. Gibbs, R. J., Stewart, J. & Poxton, I. R. (2004). The distribution of, and antibody response to, the core lipopolysaccharide region of Escherichia coli isolated from the faeces of healthy humans and cattle. J Med Microbiol 53, 959-964.
15. Green, L. C., Wagner, D. A., Glogowski, J., Skipper, P. L., Wishnok, P. S. & Tannenbaum, S. R. (1982). Analysis of nitrate, nitrite and [15N]nitrate in biological fluids. Anal Biochem 126, 131-138.
16. Gyimah, J. E. & Panigrahy, B. (1985). Immunogenicity of an Escherichia coli (serotype O1) pili vaccine in chickens. Avian Dis 29, 1078-1083.
17. Hancock, I. C. & Poxton, I. R. (1988). Bacterial Cell Surface Techniques, pp. 90-93. Chichester, UK: Wiley.
18. Kaiser, P., Rothwell, L., Galyov, E. E., Barrow, P. A., Burnside, J. & Wigley, P. (2000). Differential cytokine expression in avian cells in response to invasion by Salmonella typhimurium, Salmonella enteritidis and Salmonella gallinarum. Microbiology 146, 3217-3226.
19. Kariyawasam, S., Wilkie, B. N., Hunter, D. B. & Gyles, C. L. (2002). Systemic and mucosal antibody responses to selected cell surface antigens of avian pathogenic Escherichia coli in experimentally infected chickens. Avian Dis 46, 668-678.
20. Manthey, C. L. & Vogel, S. N. (1994). Elimination of trace endotoxin protein from rough chemotype LPS. J Endotoxin Res 1, 84-92.
21. Moody, A., Sellers, S. & Bumstead, N. (2000). Measuring infectious bursal disease virus RNA in blood by multiplex real-time quantitative RT-PCR. J Virol Methods 85, 55-64.
22. Morrison, D. C. & Ryan, J. L. (1987). Endotoxins and disease mechanisms. Annu Rev Med 38, 417-432.
23. Müller-Loennies, S., Di Padova, F., Brade, L., Brade, H. & Rietschel, E. Th. (2005). Anti-endotoxin antibodies - a cross-reactive and cross-protective monoclonal antibody against a conserved epitope of Escherichia coli and Salmonella enterica. Intensivmed Notfallmed 42, 27-38.
24. Nagaraja, K. V., Emery, D. A., Jordan, K. A., Sivanandan, V., Newman, J. A. & Pomery, B. S. (1984). Effect of ammonia on the quantitative clearance of Escherichia coli from lungs, air sacs and livers of turkeys aerosol vaccinated against Escherichia coli. Am J Vet Res 45, 392-395.
25. Parmentier, H. K., Klompen, A. L., De Vries Reilingh, G. & Lammers, A. (2008). Effect of concurrent intratracheal lipopolysaccharide and human serum albumin challenge on primary and secondary antibody responses in poultry. Vaccine 26, 5510-5520.
26. Peighambari, S. M., Hunter, D. B., Schewen, P. E. & Gyles, C. L. (2002). Safety, immunogenicity and efficacy of two Escherichia coli cya, crp mutants as vaccines for broilers. Avian Dis 46, 287-297.
27. Poxton, I. R. (1995). Antibodies to lipopolysaccharide. J Immunol Methods 186, 1-15.
28. Scott, B. B. & Barclay, G. R. (1987). Endotoxin-polymyxin complexes in an improved enzyme-linked absorbent assay for IgG antibodies in blood donor sera to Gram-negative endotoxin core glycolipids. Vox Sang 52, 272-280.
29. Trampel, D. W. & Griffith, R. W. (1997). Efficacy of aluminum hydroxide-adjuvanted Escherichia coli bacterin in turkey poults. Avian Dis 41, 263-268.
30. Westphal, O. (1975). Bacterial endotoxin. Int Arch Allergy Appl Immunol 49, 1-43.
31. Wigley, P. & Kaiser, P. (2003). Avian cytokines in health and disease. Rev Bras Cienc Avic 5, 1-14.
32. Xing, Z. & Schat, K. A. (2000). Expression of cytokine genes in Marek's disease virus infected chickens and chicken embryo fibroblasts cultures. Immunology 100, 70-71.